Evidence map›Paper›PMID 38321127›Full record

ArticleScientific reports2024

Innovative high fat diet establishes a novel zebrafish model for the study of visceral obesity.

Katarzyna Smolińska, Jan Sobczyński, Aleksandra Szopa, Artur Wnorowski, Ewa Tomaszewska, Siemowit Muszyński, Anna Winiarska-Mieczan, Tomasz Czernecki, Agata Bielak, Katarzyna Dobrowolska and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Katarzyna SmolińskaChronic Wounds Laboratory, Medical University of Lublin, Chodźki St. 7, 20-093, Lublin, Poland. katarzyna.smolinska@umlub.pl.
Jan SobczyńskiDepartment of Clinical Pharmacy and Pharmaceutical Care, Medical University of Lublin, Chodźki St. 1, 20-093, Lublin, Poland.
Aleksandra SzopaDepartment of Clinical Pharmacy and Pharmaceutical Care, Medical University of Lublin, Chodźki St. 1, 20-093, Lublin, Poland.
Artur WnorowskiDepartment of Biopharmacy, Medical University of Lublin, 4A Chodźki St. 4A, 20-093, Lublin, Poland.
Ewa TomaszewskaDepartment of Animal Physiology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Akademicka St. 12, 20-950, Lublin, Poland.
Siemowit MuszyńskiDepartment of Biophysics, University of Life Sciences in Lublin, Akademicka St. 13, 20-950, Lublin, Poland.
Anna Winiarska-MieczanInstitute of Animal Nutrition and Bromatology, University of Life Sciences in Lublin, Akademicka St. 13, 20-950, Lublin, Poland.
Tomasz CzerneckiDepartment of Biotechnology, Microbiology and Human Nutrition, Dietitian Service, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna 8, 20-704, Lublin, Poland.
Agata BielakInstitute of Animal Nutrition and Bromatology, University of Life Sciences in Lublin, Akademicka St. 13, 20-950, Lublin, Poland.
Katarzyna DobrowolskaFaculty of Biology and Biotechnology, Maria Curie Sklodowska University, Akademicka St. 19, 20-033, Lublin, Poland.
Kacper SmolińskiFaculty of Biology, Warsaw University, Żwirki I Wigury St. 101, 02-089, Warsaw, Poland.
Renata KlebaniukInstitute of Animal Nutrition and Bromatology, University of Life Sciences in Lublin, Akademicka St. 13, 20-950, Lublin, Poland.
Piotr DobrowolskiDepartment of Functional Anatomy and Cytobiology, Maria Curie Sklodowska University, Akademicka St. 19, 20-033, Lublin, Poland. piotr.dobrowolski@mail.umcs.pl.

Funding

Uniwersytet Medyczny w Lublinie DS 448
6 · The paper itself

Abstract

Obesity is a complex chronic condition associated with multiple health risks, including visceral obesity, which is particularly detrimental. To gain insight into the mechanisms underlying obesity and its associated pathologies, a novel zebrafish model was established using an innovative high-fat diet (HFD). The primary goal was to induce visceral obesity in zebrafish and study the associated structural changes. To achieve this, a unique HFD consisting of 40% beef fat (HFD40) was developed and supplemented with magnesium aluminometasilicate to improve stability in a high humidity environment. Feeding regimens were initiated for both juvenile (starting at 2 weeks post-fertilization, lasting 18 weeks) and adult zebrafish (3 months post-fertilization, 8 weeks feeding duration). The innovative dietary approach successfully induced visceral obesity in both juvenile and adult zebrafish. This new model provides a valuable tool to study obesity-related pathologies, metabolic syndrome, and potential therapeutic interventions. Most importantly, the low-cost and easy-to-prepare composition of HFD40 was seamlessly incorporated into the water without the need for separation, was readily absorbed by the fish and induced rapid weight gain in the zebrafish population. In conclusion, this study presents a novel HFD40 composition enriched with a high beef fat concentration (40%), which represents a significant advance in the development of an experimental zebrafish model for the study of visceral obesity and associated metabolic changes.

Indexed as

Diet, High-FatObesity, AbdominalAnimalsCattleObesityWeight GainZebrafish

Identifiers

PMID38321127
PMCPMC10847117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.